Crystalline form of -3-(1h-indol-3-yl)-4-[2-(4-methyl-piperazin-1-yl)-quinazolin-4-yl]-pyrrole-2,5-dione acetate, pharmaceutical composition comprising it, process for its preparation and use thereof for the preparation of a pharmacological agent

摘要

The invention relates to a new crystalline form of the acetate salt of which may be used, for example, for prevention or treatment of transplant rejection.